まとめ
大動脈の転移のためのマスタード手術を受けた乳児は,依然として肺血管阻塞性疾患を発症することがあります. 早期の矯正手術は,常にこの深刻な術後の合併症を予防するわけではありません.
科学分野:
- ペディアトリック・カルディオロジー
- 生まれながらの心臓病 (Congenital Heart Disease) とは,先天性心臓病 (Congenital Heart Disease) とは,先天性心臓病 (Congenital Heart Disease) とは,先天性心臓病 (Congenital Heart Disease) とは,先天性心臓病 (Congenital Heart Disease) とは,先天性心臓病 (Congenital Heart Disease) とは,先天性心臓病 (Congenital Heart Disease) とは,先天性心臓病 (Congenital Heart Disease) とは,先天性心臓病 (Congenital Heart Disease) とは,先天性心臓病 (Congenital Heart Disease) とは,先天性心臓病 (Congenital Heart Disease) とは,先天性心臓病 (Congenital Heart Disease) とは,先天性心臓病 (Congenital Heart Disease) とは,先天性心臓病 (Congenital Heart Disease) とは,
- 血管生物学 血管生物学
背景:
- 大動脈の転移 (TGA) と無傷の心室隔膜は,複雑な先天性心不全です.
- マスタード手術は,TGAにおける血流のルートを変更するための緩和的な手術である.
- 肺血管阻害性疾患 (PVOD) は,乳幼児の心臓手術後の潜在的な合併症です.
関連する概念動画
01:17Pulmonary Cycle: Exhalation
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:27Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...